Shares of Prometheus Biosciences soared 70% in premarket trading on Monday after Merck & Co. announced that it would acquire the company in a $10.8 billion deal. The deal, announced Sunday, gives ...
Just days before a planned celebration of its new Rahway headquarters, Merck announced another milestone: It officially closed on its previously announced $10.8 billion acquisition of San Diego-based ...
Merck has agreed to acquire clinical-stage biotech company Prometheus Biosciences for $200 per share in cash, with the deal expected to close late in Q2 or early in Q3. The acquisition will advance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback